A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy

NCT02008227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1225

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Atezolizumab
DRUG: Docetaxel

Sponsor

Hoffmann-La Roche